Retatrutide is a groundbreaking medication generating considerable buzz in the obesity treatment field. This remarkable peptide, developed by Eli Lilly, functions as a dual GIP and GLP-1 site agonist. Essentially, it replicates the action of these body's hormones, which influence appetite and support satiety. Clinical trials have demonstrated im… Read More